GLP-1 Receptors in Nicotine and Opioid Craving Reduction
GLP-1 drugs reduce craving for nicotine and opioids by rewiring the brain's reward circuitry itself.
Rohan Park
Columnist
Rohan Park is a columnist at glpletter covering emerging glp-1 indications. Based in Cape Town, Rohan has written for glpletter since 2018.
1 story · Cape Town
GLP-1 drugs reduce craving for nicotine and opioids by rewiring the brain's reward circuitry itself.